ArticleScientific reports2025

Riboflavin-PLGA nanoparticles enhance the effectiveness of the pyruvate carboxylase inhibitor ZY-444 in targeting lipogenesis in colon and breast cancer.

Siraprapa Siritutsoontorn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.